ChartRow logo
Share this page
BSX
$44.39+0.57%
as of close, Oct 16, 2026
☾ AH $44.39 +0.57%
PeersMRNALLYMDTUNHJNJTMO

BSX financial statements

The full income statement, balance sheet, and cash-flow statement for Boston Scientific Corporation (BSX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 1.47B2024-09 1.47B2024-12 1.48B2025-03 1.48B2025-06 1.48B2025-09 1.48B2025-12 1.48B2026-03 1.49B2026-06 1.45B-1.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue20.1B+19.9%16.7B+17.6%14.2B+12.3%12.7B+6.7%11.9B+19.9%
13.9B+20.6%11.5B+16.1%9.90B+13.4%8.73B+6.7%8.18B+26.8%
Cost of revenue6.22B+18.3%5.26B+21.0%4.34B+9.8%3.96B+6.6%3.71B+7.1%
10.2B+15.2%8.89B+17.7%7.55B+6.7%7.08B+1.4%6.98B+6.9%
Research & development2.05B+27.1%1.61B+14.2%1.41B+6.9%1.32B+9.9%1.20B+5.3%
Selling, general & administrative6.89B+15.1%5.98B+15.3%5.19B+14.8%4.52B+3.7%4.36B+15.1%
Restructuring101M+531.3%16.0M-76.8%69.0M+187.5%24.0M-40.0%40.0M-23.1%
Amortization of intangibles897M+4.8%856M+3.4%828M+3.1%803M+8.4%741M-6.1%
Provision for credit losses56.0M+36.6%41.0M-18.0%50.0M+42.9%35.0M+25.0%28.0M-42.9%
Operating income3.61B+38.8%2.60B+11.1%2.34B+42.1%1.65B+37.5%1.20B+1598.8%
Interest expense349M+14.4%305M+15.1%265M-43.6%470M+37.8%341M-5.5%
Other non-operating income-228M+29.0%-321M+10.3%-358M+29.5%-508M-333.0%218M-39.8%
Pre-tax income3.38B+48.3%2.28B+15.0%1.99B+74.0%1.14B+6.0%1.08B+1462.0%
Income tax493M+13.1%436M+10.9%393M-11.3%443M+1130.6%36.0M+1700.0%
2.89B+56.7%1.85B+16.0%1.59B+128.1%698M-32.9%1.04B+1369.5%
Net income to non-controlling interest-6.00M+25.0%-8.00M-700.0%-1.00M0.000.00
Net income to common2.90B+56.4%1.85B+18.0%1.57B+144.5%642M-34.8%985M+956.5%
$1.94+55.2%$1.25+16.8%$1.07+137.8%$0.45-34.8%$0.69+962.5%
EPS (basic)$1.96+55.6%$1.26+16.7%$1.08+140.0%$0.45-34.8%$0.69+962.5%
Weighted-avg shares (basic)1.48B+0.6%1.47B+1.3%1.45B+1.6%1.43B+0.6%1.42B+0.4%
Weighted-avg shares (diluted)1.49B+0.6%1.49B+1.5%1.46B+1.7%1.44B+0.4%1.43B+1.2%
Dividends per share——$0.02-50.2%$0.04-0.6%$0.04+95.1%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
8.79B+27.1%6.92B+6.2%6.51B+13.1%5.76B-8.8%6.32B-5.6%
Cash & equivalents1.97B+374.6%414M-52.1%865M-6.8%928M-51.8%1.93B+11.0%
Inventory2.94B+4.7%2.81B+13.1%2.48B+33.0%1.87B+16.0%1.61B+19.2%
Prepaid expenses660M-20.6%831M+33.8%621M-15.0%731M-8.5%799M+6.4%
Other current assets—831M+33.8%621M-15.0%731M-8.5%799M+6.4%
43.7B+10.9%39.4B+12.1%35.1B+8.2%32.5B+0.7%32.2B+4.7%
Property, plant & equipment4.04B+22.5%3.29B+15.2%2.86B+16.9%2.45B+8.6%2.25B+8.1%
Operating lease right-of-use465M+3.6%449M+2.3%439M+13.7%386M-11.3%435M-5.0%
Goodwill18.3B+7.0%17.1B+18.8%14.4B+11.4%12.9B+7.8%12.0B+20.5%
Intangible assets7.02B+5.0%6.68B+11.3%6.00B+1.7%5.90B-3.6%6.12B+3.4%
Deferred tax assets3.67B+0.5%3.65B-4.8%3.84B-2.6%3.94B-4.8%4.14B-1.6%
Other non-current assets1.19B-32.4%1.75B+14.6%1.53B+2.1%1.50B+6.4%1.41B-26.6%
5.44B-15.0%6.40B+29.7%4.93B+29.7%3.80B-11.0%4.27B+16.1%
Accounts payable1.14B+19.2%960M+1.9%942M+9.3%862M+8.6%794M+54.8%
Accrued liabilities3.20B+15.4%2.77B+4.8%2.65B+22.5%2.16B-11.3%2.44B+10.9%
Deferred revenue313M+2.3%306M+15.0%266M+20.9%220M+5.8%208M+50.7%
Short-term & current debt299M-83.2%1.78B+234.8%531M+2555.0%20.0M-92.3%261M+1907.7%
Current lease liability90.0M+11.1%81.0M+6.6%76.0M+24.6%61.0M-14.1%71.0M
Other current liabilities795M-10.4%887M+9.0%814M+7.0%761M-2.8%783M-18.3%
Finance lease liability (current)
1.00M————
Long-term debt11.1B+24.2%8.97B+4.6%8.57B-3.9%8.91B+1.3%8.80B-3.6%
Non-current lease liability446M+11.2%401M+2.8%390M+12.4%347M-10.8%389M-3.0%
Operating lease liability (total)536M+11.2%482M+3.4%466M+14.2%408M-11.3%460M
Finance lease liability
122M————
Deferred tax liabilities220M+41.9%155M+15.7%134M-6.9%144M-53.5%310M-6.1%
Other non-current liabilities2.40B+28.6%1.87B-4.9%1.97B-3.3%2.04B-8.3%2.22B-3.9%
24.2B+11.3%21.8B+12.9%19.3B+9.7%17.6B+5.7%16.6B+8.5%
Preferred stock0.000.000.000.000.00
Common stock17.0M+0.0%17.0M+0.0%17.0M+0.0%17.0M+0.0%17.0M+0.0%
Additional paid-in capital21.5B+2.1%21.1B+2.0%20.6B+1.8%20.3B+1.5%20.0B+1.3%
Retained earnings5.57B+108.4%2.67B+226.4%819M+209.2%-750M+46.1%-1.39B+41.5%
Treasury stock2.25B+0.0%2.25B+0.0%2.25B+0.0%2.25B+0.0%2.25B+0.0%
Accumulated other comprehensive income-610M-321.8%275M+461.2%49.0M-81.8%269M+2.3%263M+27.1%
Non-controlling interest239M+2.6%233M-6.0%248M0.00—
Total equity incl. non-controlling24.5B+11.2%22.0B+12.7%19.5B+11.1%17.6B+5.7%16.6B+8.5%
Total liabilities & equity43.7B+10.9%39.4B+12.1%35.1B+8.2%32.5B+0.7%32.2B+4.7%
Common shares issued1.75B+0.5%1.74B+0.5%1.73B+1.9%1.70B+0.5%1.69B+0.5%
Shares outstanding (cover)1.48B+0.5%1.48B+0.6%1.47B+2.3%1.43B+0.6%1.43B+0.7%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
4.53B+32.0%3.44B+37.2%2.50B+64.0%1.53B-18.4%1.87B+24.0%
Depreciation & amortization1.37B+7.8%1.27B+6.1%1.20B+5.3%1.14B+3.9%1.09B-2.7%
Intangible amortization897M+4.8%856M+3.4%828M+3.1%803M+8.4%741M-6.1%
Share-based compensation299M+12.4%266M+14.2%233M+5.9%220M+13.4%194M+14.1%
Deferred income taxes-12.0M+86.7%-90.0M-223.3%73.0M+1142.9%-7.00M+95.1%-142M-67.1%
Change in receivables269M-23.4%351M+47.5%238M+8.2%220M-21.1%279M+183.3%
Change in inventory188M-17.5%228M-65.5%660M+105.6%321M-7.2%346M+432.3%
Other operating activities42.0M+2000.0%2.00M-95.7%47.0M-62.4%125M+60.3%78.0M
-2.64B+53.6%-5.69B-120.9%-2.57B-28.0%-2.01B-25.9%-1.60B-288.6%
Capital expenditure876M+10.9%790M+11.1%711M+20.9%588M+6.1%554M+47.3%
Free cash flow3.66B+38.3%2.65B+47.6%1.79B+91.0%938M-28.7%1.32B+16.3%
Acquisitions1.59B-65.7%4.64B+156.2%1.81B+17.4%1.54B-31.7%2.26B+75166.7%
Proceeds from sale of PP&E—3.00M-25.0%4.00M-66.7%12.0M-14.3%14.0M+16.7%
Other investing activities-84.0M-265.2%-23.0M+37.8%-37.0M+47.1%-70.0M+14.6%-82.0M+5.7%
-395M-121.8%1.81B+36180.0%5.00M+100.9%-548M-476.8%-95.0M-132.4%
Long-term debt issued1.56B-27.4%2.15B0.00-100.0%3.27B0.00-100.0%
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00-100.0%
Common stock repurchased0.000.000.000.000.00-100.0%
Dividends paid0.000.00-100.0%28.0M-49.1%55.0M+0.0%55.0M+96.4%
Other financing activities7.00M+800.0%-1.00M+98.7%-77.0M——
FX effect on cash42.0M+481.8%-11.0M-175.0%-4.00M+55.6%-9.00M-50.0%-6.00M-200.0%
Net change in cash1.54B+442.4%-450M-542.9%-70.0M+93.3%-1.04B-702.3%173M-87.5%
Interest paid319M+27.6%250M-3.5%259M-42.4%450M+33.1%338M-5.8%
Income taxes paid561M-14.5%656M+28.1%512M-22.7%662M+119.2%302M+45.9%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap141B+7.3%132B+55.6%84.7B+27.8%66.3B+9.3%60.6B+19.0%
P/E48.9×-31.5%71.4×+3.5%69.0×-32.0%101.5×+74.3%58.2×
P/S7.0×-10.5%7.9×+27.9%6.2×+16.7%5.3×+3.4%5.1×-0.8%
P/B5.8×-3.6%6.1×+35.0%4.5×+19.4%3.8×+3.0%3.6×+9.7%
P/FCF38.7×-22.4%49.8×-0.1%49.9×-58.2%119.4×+159.3%46.1×+2.3%
Earnings yield2.0%+46.0%1.4%-3.4%1.4%+47.2%0.99%-42.6%1.7%
FCF yield2.6%+28.8%2.0%+0.1%2.0%+139.3%0.84%-61.4%2.2%-2.3%
Dividend yield——0.03%-60.2%0.08%-8.7%0.09%+65.1%
Source filing10-K10-K10-K10-K10-K

About this data

Source: BSX’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BSX filings on SEC EDGAR → Not investment advice.